{ "schema_version": "stem-ai-regulatory-basis-registry-v1", "as_of": "May 2026", "display_note": { "title": "Regulatory basis note", "body_line_1": "Aligned to current official source classes as of June 2026: EU AI Act (Regulation (EU) 2024/1689), FDA QMSR, FDA AI-enabled device guidance themes, IMDRF SaMD/GMLP frameworks, and ICH M15 General Principles for Model-Informed Drug Development.", "body_line_2": "This is a traceability aid, not a compliance or clearance determination." }, "sources": [ { "id": "eu_ai_act_2024_1689", "jurisdiction": "EU", "title": "EU AI Act (Regulation (EU) 2024/1689)", "status": "law_in_force", "published_date": "2024-07-12", "effective_date": "2024-08-01", "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32024R1689", "used_for": ["article_10", "article_11", "article_12", "article_13", "article_14", "article_15"], "notes": "Use as legal source text; do not infer application milestones from this field alone." }, { "id": "eu_ai_act_timeline_ec", "jurisdiction": "EU", "title": "European Commission AI Act timeline and implementation page", "status": "final_framework", "published_date": null, "effective_date": "2026-08-02", "url": "https://digital-strategy.ec.europa.eu/en/policies/regulatory-framework-ai", "used_for": ["application_timeline"], "notes": "Use for application dates and phased implementation context." }, { "id": "fda_qmsr", "jurisdiction": "US", "title": "FDA Quality Management System Regulation (QMSR)", "status": "final_guidance", "published_date": "2024-01-31", "effective_date": "2026-02-02", "url": "https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-management-system-regulation-qmsr", "used_for": ["qms", "iso_13485_aligned_scaffolding"], "notes": "Use for FDA quality-system-aligned structural evidence references." }, { "id": "fda_mlmd_transparency_2024", "jurisdiction": "US", "title": "Transparency for Machine Learning-Enabled Medical Devices: Guiding Principles", "status": "final_guidance", "published_date": "2024-06-13", "effective_date": null, "url": "https://www.fda.gov/medical-devices/software-medical-device-samd/transparency-machine-learning-enabled-medical-devices-guiding-principles", "used_for": ["transparency", "ifu_scaffolding", "workflow_fit", "limitations"], "notes": "Use for transparency-oriented note generation, not compliance conclusions." }, { "id": "fda_pccp_2025", "jurisdiction": "US", "title": "Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions", "status": "final_guidance", "published_date": "2025-08-18", "effective_date": null, "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial", "used_for": ["pccp_readiness", "change_control", "impact_assessment"], "notes": "Use for versioned change evidence and planned modification scaffolding." }, { "id": "imdrf_samd_clinical_eval_2017", "jurisdiction": "IMDRF", "title": "Software as a Medical Device (SaMD): Clinical Evaluation", "status": "final_framework", "published_date": "2017-09-21", "effective_date": null, "url": "https://www.imdrf.org/documents/software-medical-device-samd-clinical-evaluation", "used_for": ["scientific_validity_signal", "analytical_validation_signal", "clinical_context_boundary_signal"], "notes": "Use for evidence family language; do not claim direct clinical validation." }, { "id": "imdrf_gmlp_2025", "jurisdiction": "IMDRF", "title": "Good machine learning practice for medical device development: Guiding principles", "status": "final_framework", "published_date": "2025-01-29", "effective_date": null, "url": "https://www.imdrf.org/documents/good-machine-learning-practice-medical-device-development-guiding-principles", "used_for": ["gmlp", "lifecycle_discipline", "human_ai_team", "risk_management"], "notes": "Use for lifecycle-discipline and transparency-adjacent references." }, { "id": "ich_m15_midd_2026", "jurisdiction": "ICH", "title": "ICH M15 General Principles for Model-Informed Drug Development", "status": "final_guideline", "published_date": "2026-01-01", "effective_date": null, "url": "https://www.ich.org/page/multidisciplinary-guidelines", "used_for": [ "midd_context_of_use", "model_verification", "model_validation_applicability", "model_analysis_plan", "model_analysis_report", "code_data_submission", "regulatory_framework_signal" ], "sections": { "2.1.2": "Context of Use — role and scope of model must be explicitly described", "3": "Model Evaluation — Verification, Validation, and Applicability Assessment", "4.1": "Model Analysis Plan (MAP) — pre-defined documentation of intended analysis", "4.2": "Model Analysis Report (MAR) — results, evaluation, and technical criteria", "4.3": "Documentation for Regulatory Submissions — code, data, and scripts must be available for review" }, "notes": "Post-hoc alignment: STEM BIO-AI rubric items were designed before M15 adoption. Alignment is confirmed but not causally derived from M15. Cite as supporting regulatory context, not as compliance determination." } ] }